This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Diazepam Binding Inhibitor (DBI) ELISA Kit-Sandwich
Product Overview
BioVenic Mouse Diazepam Binding Inhibitor (DBI) ELISA Kit-Sandwich is designed for the quantitative determination of Mouse DBI in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.
Specifications
Target Information
Acyl-CoA-binding protein (Dbi) exhibits a strong affinity for medium- and long-chain acyl-CoA esters, suggesting it may serve as an intracellular carrier for these molecules. Additionally, it can displace diazepam from the benzodiazepine (BZD) binding site on the GABA type A receptor, implying a potential role as a neuropeptide in modulating GABA receptor activity. DBI, an endogenous neuropeptide, interacts with benzodiazepine receptors, thereby influencing the function of γ-aminobutyric acid type A receptors (GABA_ARs). Research indicates that DBI is essential in the mouse hippocampus, impacting synaptic plasticity and learning and memory by modulating GABA_ARs-mediated synaptic inhibition.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.